KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Raw Materials (2016)

Historic Raw Materials for AbbVie (ABBV) over the last 5 years, with Q2 2016 value amounting to $132.0 million.

  • AbbVie's Raw Materials rose 476.19% to $132.0 million in Q2 2016 from the same period last year, while for Jun 2016 it was $132.0 million, marking a year-over-year increase of 476.19%. This contributed to the annual value of $169.0 million for FY2015, which is 974.03% up from last year.
  • As of Q2 2016, AbbVie's Raw Materials stood at $132.0 million, which was up 476.19% from $155.0 million recorded in Q1 2016.
  • In the past 5 years, AbbVie's Raw Materials registered a high of $261.0 million during Q4 2013, and its lowest value of $126.0 million during Q2 2015.
  • Over the past 5 years, AbbVie's median Raw Materials value was $163.0 million (recorded in 2015), while the average stood at $188.2 million.
  • Over the last 5 years, AbbVie's Raw Materials had its largest YoY gain of 974.03% in 2015, and its largest YoY loss of 4501.99% in 2015.
  • Quarter analysis of 5 years shows AbbVie's Raw Materials stood at $258.0 million in 2012, then increased by 1.16% to $261.0 million in 2013, then plummeted by 41.0% to $154.0 million in 2014, then increased by 9.74% to $169.0 million in 2015, then decreased by 21.89% to $132.0 million in 2016.
  • Its last three reported values are $132.0 million in Q2 2016, $155.0 million for Q1 2016, and $169.0 million during Q4 2015.